Updates and perspectives from our industry experts, scientists and product leaders.
Uncover the emerging role of AI in the revolutionary field of gene therapy and how it is paving the way for groundbreaking advancements.
Discover how Form Bio and Google Cloud’s Multiomics Suite will empower life scientists to accelerate research, development, and pre-clinical studies in personalized medicine and gene therapies.
Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.
We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.
Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.
Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.
Austin Day, PhD
July 26, 2023
Despite having access to diverse data and a vast number of parameters, new DNA large language models often struggle to learn hard tasks. Our AI expert, Austin, shares his insights on the possible reasons why.
Jill Roughan, PhD
May 29, 2023
Discover the progression of AI from inception to present-day, and how it powers the efficient analysis of big data, revolutionizes gene therapy development, and advances biomanufacturing.
Claire Aldridge, PhD
May 15, 2023
Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.
Sasha Maslova
April 18, 2023
Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.
April 4, 2023
Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.
March 22, 2023
Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.
Nick Ketz, PhD
March 8, 2023
Transformer based architectures are uniquely efficient and powerful when used to process structured data. Read this blog to learn how they can be customized, adapted and applied to AAV construct optimization.
February 23, 2023
In this article, we take a look at the role of viral vectors in gene therapy clinical trials, including current challenges and leveraging artificial intelligence to advance the field.
February 14, 2023
Want to know more about the foundational types and common tools to use for RNA-Seq data visualization in gene therapy development? Read this blog to find out.
February 7, 2023
Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.
February 1, 2023
As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.
January 31, 2023
DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.
November 20, 2023
Learn the essential steps for characterizing your gene therapy product with bioreactor simulator runs in your pre-clinical development stage.
October 17, 2023
Learn how to overcome product quality challenges when moving from pre-clinical to commercialization of AAV gene therapy.
November 7, 2023
Explore the boundless potential at the intersection of life sciences and AI. Discover actionable insights to embark on this journey leveraging cutting-edge technology.